Theralase Technologies Inc. logo

Theralase Technologies Inc. (TLTFF)

Market Closed
3 Jun, 20:00
OTCQB OTCQB
$
0. 1690
+0.009
+5.63%
$
48.05M Market Cap
- P/E Ratio
- Div Yield
58,400 Volume
- Eps
$ 0.16
Previous Close
Add Transaction
Day Range
0.1688 0.169
Year Range
0.1 0.31
Want to track TLTFF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TLTFF closed today higher at $0.17, an increase of 5.63% from yesterday's close, completing a monthly decrease of -0.59% or $0. Over the past 12 months, TLTFF stock gained 40.83%.
TLTFF is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on OTCQB (USD).

TLTFF Chart

People also search for

Cell Source Inc.
$ 0.77
-3.75%
Telescope Innovations Corp.
$ 0.61
+12.19%
Vivos Inc.
$ 0.06
-0.41%
Security Devices International, Inc.
$ 1.16
+0.87%
Inhibitor Therapeutics Inc.
$ 0.08
-1.18%
Theralase Technologies Inc. (TLTFF) Q1 2025 Earnings Call Transcript

Theralase Technologies Inc. (TLTFF) Q1 2025 Earnings Call Transcript

Theralase Technologies Inc. (OTCQX:TLTFF) Q1 2025 Earnings Conference Call June 9, 2025 11:00 AM ET Company Participants Kristina Hachey - CFO & Director Matthew Perraton - Corporate Participant Roger John Dumoulin-White - President, CEO & Director Matthew Perraton Good morning, everyone, and thank you for joining us today. I'm Matthew Perraton, Investor Relations Manager at Theralase Technologies, Inc., and it's a pleasure to welcome our shareholders and stakeholders to our first quarter 2025 Investor Conference Call.

Seekingalpha | 11 months ago
Theralase Technologies Inc. (TLTFF) Q4 2024 Earnings Call Transcript

Theralase Technologies Inc. (TLTFF) Q4 2024 Earnings Call Transcript

Theralase Technologies Inc. (OTCQX:TLTFF) Q4 2024 Earnings Conference Call March 19, 2025 11:00 AM ET Company Participants Matthew Perraton - Chairman of the Board Kristina Hachey - Chief Financial Officer Roger Dumoulin-White - President and Chief Executive Officer Conference Call Participants Matthew Perraton Good morning, everyone. My name is Matthew Perraton and I will be hosting Theralase Technologies Inc's Quarterly Investor Conference Call today.

Seekingalpha | 1 year ago
Theralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call Transcript

Theralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call Transcript

Theralase Technologies Inc. (OTCQX:TLTFF) Q3 2024 Earnings Conference Call December 4, 2024 11:00 AM ET Company Participants Matthew Perraton - Chairman of the Board Kristina Hachey - Chief Financial Officer Roger Dumoulin-White - President and Chief Executive Officer Conference Call Participants Matthew Perraton Good morning, everyone. My name is Matthew Perraton and I will be hosting Theralase Technologies Inc's Quarterly Investor Conference Call today.

Seekingalpha | 1 year ago

Theralase Technologies Inc. (TLTFF) FAQ

What is the stock price today?

The current price is $0.1690.

On which exchange is it traded?

Theralase Technologies Inc. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is TLTFF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 48.05M.

Has Theralase Technologies Inc. ever had a stock split?

No, there has never been a stock split.

Theralase Technologies Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Roger John Dumoulin-White CEO
OTCQB Exchange
88337V100 CUSIP
CA Country
14 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

The fund is designed as an exchange-traded securities fund with a unique investment objective focused on providing daily exposure to the OBX Index, with a specific mechanism that amplifies the inverse movement of the index. This financial instrument is engineered to double the opposite performance of the OBX Index on a daily basis. This means that for each 1% decrease in the OBX Index, the fund aims to increase its value by approximately 2%, and conversely, for each 1% increase in the index, the fund's value is expected to decrease by approximately 2%. This leverage effect is central to the fund's strategy, although it's important to note that the fund and the Management Company do not guarantee a specific return. The OBX Index itself is a key barometer of the Oslo stock exchange’s market, comprising the 25 most liquid equities listed. It is a market-value weighted index, and its composition is revisited biannually to accurately reflect the market dynamics, guided by the Oslo Börs Index Methodology. This disciplined approach to index configuration ensures the OBX Index remains a relevant and representative benchmark of Norway's leading stock exchange.

Products and Services

Through its distinctive investment strategy, the fund offers a singular product designed to inverse-track the OBX Index with a leverage factor:

  • Inverse Leveraged Exchange-Traded Fund (ETF)
  • This fund provides investors with the opportunity to gain twice the inverse exposure to the daily performance of the OBX Index. It's a sophisticated financial instrument intended for investors looking to capitalize on or hedge against the downward movements of the Norwegian market's most liquid equities. The fund operates with a clear aim to double the opposite outcome of the OBX Index's daily performance, making it an aggressive investment option relative to traditional equity or index funds. Leveraged inverse ETFs like this are particularly suited for short-term trading strategies, given their daily reset mechanism, which can lead to compounding effects over multiple periods. It's crucial for potential investors to understand that the fund's performance is closely tied to daily market fluctuations, and the intended 2x inverse leverage outcome is calculated on a day-to-day basis.

Contact Information

Address: 41 Hollinger Road
Phone: 416 699 5273